Filana Therapeutics (FLNA) Other Non-Current Assets (2010 - 2021)

Filana Therapeutics has reported Other Non-Current Assets for 11 years, with the latest figure at $399000.0 in Q4 2021.

• On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $399000.0 in Q4 2021; TTM through Dec 2021 was $399000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $399000.0, changed N/A from the prior year.
• Other Non-Current Assets was $399000.0 for Q4 2021 at Filana Therapeutics, up from $199000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.4 million in Q2 2021, with the low at $12000.0 in Q4 2017.
• Average Other Non-Current Assets over 4 years is $193818.2, with a median of $12000.0 recorded in 2017.
• The sharpest annual moves came in 2018 and 2019: Other Non-Current Assets changed 0.0% in 2018, then plunged 60.0% in 2019.
• Over 4 years, Other Non-Current Assets stood at $12000.0 in 2017, then changed by 0.0% to $12000.0 in 2018, then changed by 0.0% to $12000.0 in 2019, then jumped by 3225.0% to $399000.0 in 2021.
• The last three Other Non-Current Assets figures came in at $399000.0 (Q4 2021), $199000.0 (Q3 2021), and $1.4 million (Q2 2021), per Business Quant data.